Frontiers in oncology.
1 Introduction 1.1 World Health Organization classification of tumors of the CNS. Despite significant improvements in our understanding of the molecular basis of cancer, understanding the natural history of brain tumors is becoming a difficult task Intracranial neoplasms are a group of complex and heterogeneous lesions across the spectrum of benign and malignant tumors having varied treatments ...
See all (60) Learn more about Research Topics. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies.4 days ago · timothy james kinsella. Department of Radiation Oncology, Warren Alpert Medical School, Brown University. Providence, United States. Specialty Chief Editor. Radiation Oncology. Frontiers has a community retraction protocol in place to retract papers where serious concerns have been raised and validated by the community that warrant retraction, including ethical concerns, honest errors or scientific misconduct. Explores research into the molecular and cellular mechanisms of carcinogenesis and cancer progression.Learn more about Research Topics. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors.
Mar 30, 2017 ... Synthetic biology promises to revolutionize cancer care by offering permanent cures to patients with historically untreatable malignancies.
Cleveland Clinic Abu Dhabi organizes Frontiers In Advanced Hepato-Biliary Cancers And Transplant Oncology 2024 conference from the 27 April – 28 April 2024 to get to the latest advancements in liver and bile duct cancers.Marry M. van den Heuvel-Eibrink. Archie Bleyer. Frontiers in Oncology. doi 10.3389/fonc.2024.1336714. 838 views. Part of a multidisciplinary journal, this section publishes quality basic science, translational studies, and clinical trials in the field of pediatric oncology.
Introduction. It has been estimated that breast cancer surpassed lung cancer as the first cause of global cancer incidence in females, with 2,261,419 new cases in 2020 ().Moreover, breast cancer is the fifth leading cause of cancer death in females and also a considerable cause of cancer death in males worldwide (1, 2).The incidence rate …Precision Medicine in Oncology. Recent advances in technology have unveiled a tremendous heterogeneity in cancer dysfunctional mechanisms. This gain of knowledge has opened a new era in oncology, which relays on the concept that each tumor is different and should be treated in a specific way depending on its distinctive …The BSc Medical Sciences with Cancer Frontiers programme is designed to provide an understanding of the scientific basis of cancer and how this relates to ...Background. Immune checkpoint inhibitors (ICIs) are a class of antitumor drug that activate lymphocytes, which then attack tumor cells by relieving immune checkpoint-mediated immune-suppression (1, 2).In 2015, two types of ICIs (nivolumab and pembrolizumab) were approved by the U.S. Food and Drug Administration for the …
Frontiers requires figures to be submitted individually, in the same order as they are referred to in the manuscript; the figures will then be automatically embedded at the end of the submitted manuscript. Kindly ensure that each figure is mentioned in the text and in numerical order.
Mechanobiology in oncology: basic concepts and clinical prospects. Michelle B. Chen 1† Yousef Javanmardi 2† Somayeh Shahreza 2 Bianca Serwinski 2,3,4 Amir Aref 5 Boris Djordjevic 2,3 Emad Moeendarbary 1,2 *. 1 Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States.
3 days ago · See all (43) Learn more about Research Topics. This section explores molecular and clinical characteristics of a broad group of malignancies with special interest on the biology and therapeutic strategies for head and neck cancer subtypes. The immunogenicity of cancer cells is a new determinant of anti-cancer immunotherapy. In addition to the development of dendritic cell-based vaccines, immune checkpoint inhibitors and adoptive T cell transfer, researchers have begun to pay more attention on the immunobiology of dead cancer cells and their correlation with the success of cancer ...Browse the latest research topics in oncology, covering various aspects of cancer biology, diagnosis, treatment and prevention. Find articles on mitochondrial dysregulation, skull-base tumours, radiation therapy, immunotherapy, nanomaterials, and more.Targeting Tumor Microenvironment and Metabolic Reprogramming in Triple-negative Breast Cancer. Weipeng Zhao. Lili Yang. Shengyu Yang. 11,564 views. 5 articles. This section explores basic science, translational and clinical aspects of Cancer Metabolism, with a particular emphasis on energy metabolism and metabolic reprogramming in cancer cells.Learn more about Research Topics. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors.Priority will be given to preclinical and translational evaluations of novel targets and functioning of the target specific therapeutics. Submissions should present significant new information on the mechanisms of targetable molecules in cancer development and metastasis and target-specific therapies. Mechanistic studies that use innovative ...Frontier Airlines is a popular choice for travelers looking for affordable flights. With its low-cost fares, the airline has gained a reputation for offering budget-friendly option...
Are you planning your next trip and considering booking a flight with Frontier Airlines? Look no further. In this ultimate guide, we will provide you with everything you need to kn... Frontiers in Oncology is a broad-scope, multidisciplinary journal covering all areas of cancer research to advance our knowledge of cancer epidemiology to improve diagnosis, therapeutics and ... Yu Zhu. Jixiang Chu. Dan Luo. Hai-Long Dai. Chengde Liao. Frontiers in Oncology. doi 10.3389/fonc.2024.1394708. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors.Frontiers in Oncology. Published by Frontiers. Online ISSN: 2234-943X. Disciplines: Geriatrics and Gerontology. Journal website Author guidelines. Top read articles. 211 reads in the past... Frontiers requires figures to be submitted individually, in the same order as they are referred to in the manuscript; the figures will then be automatically embedded at the end of the submitted manuscript. Kindly ensure that each figure is mentioned in the text and in numerical order.
francesco giovinazzo. Unit of General and Liver Transplant Surgery, Department of Medical and Surgical Sciences, Agostino Gemelli University Polyclinic (IRCCS) Rome, Italy. Specialty Chief Editor. Surgical Oncology.The Cancer Epidemiology and Prevention section aims to publish rigorous research which gives new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence. Our goal is to encourage interdisciplinary communication and collaborative research among basic scientists, epidemiologists, clinicians, and ...
Scope. This section of the journal will focus on the basic science, translational and clinical aspects of Cancer Metabolism, with a particular emphasis on energy metabolism and metabolic reprogramming in cancer cells. This broadly includes mitochondrial, glycolytic, fatty acid, as well as other forms of metabolism.brian d adams. Brain Institute of America. New Haven, United States. Associate Editor. Cancer Molecular Targets and Therapeutics.James L. Gulley. Frontiers in Oncology. doi 10.3389/fonc.2024.1376622. 218 views. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting research, discussion and new hypotheses.This Frontiers in Oncology Special Issue marks the 1st edition of a collection of selected articles published in the journal over the course of the previous calendar year, highlighting ongoing research and advances being carried out in the different disciplines of cancer research.Frontiers requires figures to be submitted individually, in the same order as they are referred to in the manuscript; the figures will then be automatically embedded at the end of the submitted manuscript. Kindly ensure that each figure is mentioned in the text and in numerical order.We conducted a rapid bibliometric evaluation of TDM in oncology to capture a snapshot of research in this area over time and explore topics that reflect development in the field. Reports with the composite, indexed term ‘therapeutic drug monitoring’ in the title and abstract were extracted from MEDLINE (inception to August 2021).Jan 9, 2024 · Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology. Frontiers has a community retraction protocol in place to retract papers where serious concerns have been raised and validated by the community that warrant retraction, including ethical concerns, honest errors or scientific misconduct. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting ...The AA of oncology drugs is traditionally supported by single-arm trials. The emphasis on randomization and control fits the 2-in-1 design well because it is the default feature of any adaptive phase 2/3 trial. Project FrontRunner also proposed a one-trial approach to support both AA and regular approval (RA) in the same phase 3 trial, on top ...Tracess B Smalley. Timothy H Tran. Frontiers in Oncology. doi 10.3389/fonc.2024.1394702. Part of a multidisciplinary journal, this section explores targetable intervenients in cancer signaling pathways and their application in drug development and therapeutics.
1 Introduction. Colorectal cancer (CRC) is the third most common cancer worldwide (colon: 1,148,515; rectum: 732,210) and the second leading cause of cancer-related deaths (colon: 935,000; rectum: 339,022) in 2020.There were about 555,000 new cases of colorectal cancer in China in 2020, accounting for 12.2% of the number of new …
The Cellular and Molecular Mechanisms of Tumor Ecosystem Remodeling during Cancer Progression or Drug Treatment in Gastrointestinal and Respiratory Cancers. Qi Liao. Xinyi Liu. Haitao Luo. 1,307 views. 2 articles. Submission open.
Terms and conditions. Part of a multidisciplinary journal, this section explores new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence.116. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat oncology biology physics (1995) 31(5):1341–6. doi: 10.1016/0360-3016(95)00060-C. CrossRef Full Text | Google ScholarDongfeng Shen. Baoli Jin. Xueqin Wu. Frontiers in Oncology. doi 10.3389/fonc.2024.1340859. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and treatment of gastric and esophageal neoplasia.Frontiers has a community retraction protocol in place to retract papers where serious concerns have been raised and validated by the community that warrant retraction, including ethical concerns, honest errors or scientific misconduct. Explores research into the molecular and cellular mechanisms of carcinogenesis and cancer progression. Here, introducing Frontiers in Oncology: Quarterly Highlights, we feature a collection of carefully selected articles published during the first quarter of 2019 across the different sections. With a record number of papers to choose from, the papers enclosed in this Special Edition highlight some of the recent advances across the different ... Yu Zhu. Jixiang Chu. Dan Luo. Hai-Long Dai. Chengde Liao. Frontiers in Oncology. doi 10.3389/fonc.2024.1394708. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors.Feb 1, 2024 ... The upcoming scientific Forum titled "New Frontiers in Cancer and Healthy Aging," organized by IBSA Foundation for Scientific Research in ...Frontiers requires figures to be submitted individually, in the same order as they are referred to in the manuscript; the figures will then be automatically embedded at the end of the submitted manuscript. Kindly ensure that each figure is mentioned in the text and in numerical order.A future TCR-T therapy encompassing multiple innovations is illustrated in Figure 15, as an example of the driving force in the E2E Platform applied across multiple modules to support the goal of developing differentiated, best-in-class TCR-T therapies as new and better treatment options for cancer patients.Artificial Intelligence (AI) has many possible applications in Oncology. One of the most promising is the potential for AI to represent and/or infer processes from real-world data. On one hand, the availability of the pattern of care is growing in opportunities (e.g. new markers, devices, drugs, etc.), constraints (guidelines, protocols, legal issues), and needs (e.g. investments, sustainable ...Telemedicine in Oncology: Delivering on an Overdue Promise in the COVID-19 Era. Telemedicine has historically been underutilized in medicine broadly, and specifically in oncology, despite the general availability of the needed infrastructure to offer it as a platform for remote care. The COVID-19 pandemic posed new risks of infection …Oncology. Oncology is a specialized field of medicine that focuses on the prevention, diagnosis, and treatment of various types of cancer. Our Research Topics explore key advancements in oncology which have led to significant breakthroughs in cancer care, such as targeted therapies, immunotherapy, and precision medicine.
Genetics, genomics and RNA-based biomarker development. Whole genome studies and focused studies of individual genes contributing to cancer molecular pathways. New rationales for bringing molecular genetic findings to the clinical oncology space. Submissions not in scope for this specialty include: Those consisting solely of …Choosing the right location for your frontier business can make or break its success. A frontier location near you not only provides convenience, but it also offers the opportunity... Learn about the different article types that you can submit to Frontiers in Oncology, a peer-reviewed open access journal. Find out the word count, figure limit, fee policy, and format requirements for each article type. Epigenetic and Metabolic Regulators of Breast Carcinogenesis. Iman Mamdouh Talaat. Maha Mohamed Saber-Ayad. Hauke Busch. Noha Mousaad Elemam. 21,657 views. 14 articles. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of …Instagram:https://instagram. capitalone creditwisesmart coupons family dollar smart couponssolar system gamesflorida cu Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology.Frontiers in Oncology publishes rigorously peer-reviewed research advancing our knowledge of cancer epidemiology, molecular pathways, diagnosis and imaging, personalized therapeutics, and novel treatment and management strategies. stragiht talkhow do i get deleted messages back drexell hunter boggs. University of Alabama at Birmingham. Birmingham, United States. Associate Editor. Radiation Oncology. Part of a multidisciplinary journal, this section explores personalized cancer treatments focusing … dc museum of natural history We conducted a rapid bibliometric evaluation of TDM in oncology to capture a snapshot of research in this area over time and explore topics that reflect development in the field. Reports with the composite, indexed term ‘therapeutic drug monitoring’ in the title and abstract were extracted from MEDLINE (inception to August 2021).Frontiers works with research institutions, libraries, consortia, and funders to support authors who want to publish in a Frontiers journal. A central invoicing platform removes the burden from authors and helps contribute to the growing number of research articles that are openly available to all. Organizations can become institutional members ...Epigenetic and Metabolic Regulators of Breast Carcinogenesis. Iman Mamdouh Talaat. Maha Mohamed Saber-Ayad. Hauke Busch. Noha Mousaad Elemam. 21,657 views. 14 articles. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of …